Potent and selective leukocyte elastase inhibitor (IC50=44nM). Displays various anti-inflammatory activities including attenuation of LTB4-induced neutrophil migration and serum cytokine levels. Reduces acute inflammatory lung injury in vivo.
Product Details
Alternative Name: | ONO-5046, N-{2-[({4-[2,2-Dimethylpropanoyl)oxy]phenyl}sulfonyl)amino]benzoyl}glycine sodium salt |
|
Formula: | C20H21N2NaO7S . 4H2O |
|
MW: | 528.5 |
|
CAS: | 201677-61-4 |
|
Purity: | ≥98% (HPLC) |
|
Identity: | Determined by NMR. |
|
Appearance: | White solid. |
|
Solubility: | Soluble in DMSO (>25mg/ml), ethanol (20mg/ml) or water (2mg/ml, warm). |
|
Shipping: | Ambient Temperature |
|
Long Term Storage: | Ambient |
|
Use/Stability: | Stable for at least 1 year after receipt when stored, as supplied, at room temperature. Stock solutions are stable for up to 3 months at -20°C. |
|
Regulatory Status: | RUO - Research Use Only |
|
Please mouse over
Product Literature References
Neutrophil elastase inhibitor (sivelestat) reduces the levels of inflammatory mediators by inhibiting NF-kB: S. Hagiwara, et al.; Inflamm. Res.
58, 198 (2009),
Abstract;
A neutrophil elastase inhibitor, sivelestat, reduces lung injury following endotoxin-induced shock in rats by inhibiting HMGB1: S. Hagiwara, et al.; Inflammation
31, 227 (2008),
Abstract;
ONO-5046, a novel inhibitor of human neutrophil elastase: K. Kawabata, et al.; Biochem. Biophys. Res. Commun.
177, 814 (1991),
Abstract;